Abstract. Although the expression of keratin 7 (K7) and K20 is considered to be a useful factor in the differential diagnosis of intrahepatic cholangiocarcinoma (ICC) and metastatic colorectal carcinoma (CRC) of the liver, a proportion of typical ICC retains K20 expression. The frequency and biological significance of K20 expression in ICC remains unclear. We analyzed the expression of K7, K19 and K20 in 66 surgically resected liver tumors consisting of 46 ICCs and 20 metastatic CRCs of the liver and 20 corresponding primary CRCs. In the 46 ICCs, K7, K19 and K20 were expressed in 40 (87%), 45 (98%) and 16 (35%) cases, respectively. K7, K19 and K20 were expressed in 1 (5%), 20 (100%) and 16 (80%) of the 20 primary CRCs and 2 (10%), 20 (100%) and 16 (80%) of the 20 metastatic CRCs, respectively. A combined K7/K20 profile was identified as a good predictor for differentiating ICC and metastatic CRC. K20 expression in ICC was significantly associated with male gender (P=0.034), hilar location (P=0.026), intraductal papillary type (P=0.006), intestinal phenotype (P<0.001) and MUC2 expression (P=0.008). Univariate analysis identified that poor patient survival was significantly associated with histological grade (P=0.020), invasion depth (P=0.005), lymph node metastasis (P=0.012), tumor stage (P=0.004) and vessel invasion (P=0.023). The tumor stage (P=0.002) was a poor independent prognostic indicator, while MUC6 expression (P=0.036) was a good independent prognostic indicator. The survival rate in patients with K20-positive ICC was lower compared to that of patients with K20-negative ICC, but was not statistically significant. Furthermore, the combined K7/ K20 immunophenotype was identified to be useful for differentiating ICC and metastatic CRC. K20-positive ICC displays specific characteristics with regards to tumor location and histological subtype. Additionally, MUC6 expression in ICC is a good independent prognostic factor, while K20 expression is more often associated with aggressive biological behavior.
Introduction
Keratins are cytoskeletal intermediate filaments, which are present in normal and malignant epithelial cells. Various keratins are expressed in a tissue-and differentiation-specific manner; therefore, every epithelial cell can be categorized by the specific pattern of its keratin expression profile (1) . Keratin 20 (K20) is consistently expressed in primary and metastatic colorectal carcinoma (CRC) and demonstrates variable reactivity in gastric and pancreatic cancer (2) . Immunohistochemical analysis for K7, K19 and K20 is considered useful when making a differential diagnosis of primary and metastatic carcinomas of the liver (3, 4) . In one study, 97% of cholangiocarcinoma (CC) and 3% of metastatic CRC tissues were diffusely positive for K7, 77% of CC and 64% of metastatic CRC tissues were diffusely positive for K19, and 10% of CC and 74% of metastatic CRC tissues were diffusely positive for K20 (3) . It was identified that the K7 + /K20 -profile has a 100% positive predictive value (PPV) for CC and the K7 -/K20 + profile has a 93% PPV for metastatic CRC (4) . In previous studies, a proportion of typical intrahepatic cholangiocarcinoma (ICC) retained K20 expression (3) (4) (5) ; however, the frequency and clinicopathological significance of K20 expression in ICC remains unclear.
In this study, we evaluated the expression of K7, K19 and K20 in 46 ICCs and 20 metastatic CRCs of the liver and 20 corresponding primary CRCs, and analyzed the clinicopathological characteristics of K20 + ICC. We also examined the correlation between K20 expression and mucin phenotype in ICC. Immunohistochemical results. K7, K19 and K20 were expressed in 40 (87.0%), 45 (97.8%) and 16 (34.8%) of the 46 ICCs, respectively (Fig. 1) . CD10, MUC2, MUC5AC and MUC6 were expressed in 13 (28.3%), 10 (21.7%), 19 (41.3%) and 6 (13.0%) of the 46 ICCs, respectively. K7, K19 and K20 were expressed in 1 (5%), 20 (100%) and 16 (80%) of the 20 primary CRCs and 2 (10%), 20 (100%) and 16 (80%) of the 20 metastatic CRCs, respectively. One K7-negative primary CRC changed to positive in metastatic CRC, while 4 K20-negative CRCs changed to K20-positive in metastatic CRCs. According to the morphology of tumor cells and mucin phenotype, the 46 ICCs were divided into 32 (69.6%) pancrea- Table III . Sensitivity, specificity and PPV of K7/20 profiles in ICC and metastatic CRC. with K20-negative ICC was 42.9±18.9 months. The 1-, 3-and 5-year survival rates in patients with K20-positive ICC were lower (41, 33 and 33%, respectively) than those of patients with K20-negative ICC (54, 42 and 34%, respectively). However, no significant survival difference was observed between patients with K20-positive and K20-negative ICC as demonstrated by a Kaplan-Meier analysis (Table IV) .
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Discussion
Previous studies have investigated the use of K immunostaining in differentiating ICC from metastatic malignant tumor from other primary sites (2) (3) (4) 8) . However, with respect to the clinicopathological and biological significance, immunohistochemical studies of K expression remain insufficient. K20 expression in ICC is significantly associated with gender, tumor location, intraductal papillary type, intestinal phenotype and MUC2 expression. Although a proportion of ICC cases express K20, combined immunostaining for K7 and K20 has been identified to be useful in differentiating ICC from metastatic CRC. Advanced tumor stage is a poor independent prognostic indicator, while MUC6 expression is a good independent prognostic indicator. Additionally, K20 expression was significantly associated with intraductal papillary growth type and MUC2 expression. ICC can be categorized into three macroscopic growth types: mass-forming, periductal infiltrative and intraductal papillary. Intraductal papillary ICC differs from other types as it has better prognosis and secreted mucin subtypes (7) . It is considered to be the biliary counterpart of intraductal mucinous neoplasms of the pancreas (9, 10) . Immunohistochemically, papillary CCs are characterized by the frequent co-expression of MUC2, CDX2 and K20 (9). Zen et al proposed three carcinogenetic pathways characterized by different immuno- phenotypes of mucin and K expression. Intraductal papillary neoplasms of the bile duct were characterized by an intestinal phenotype (MUC2 + /K20 + ), and by carcinogenesis leading to tubular adenocarcinoma with increasing MUC1 expression (11) . Genetic alterations and molecular changes vary between papillary ICC and non-papillary ICC (12) (13) (14) . The close correlation between ICC of intraductal papillary type and K20 + /MUC2 + in this study supports the hypothesis that the intraductal papillary type may be different from other types of ICC. In this study, we also identified that K20-positive ICC was closely associated with tumor location. This is in accordance with previous studies, which demonstrated that K20 expression correlated with hilar type ICC (4, 5) . The K20-positive rate varies according to the sites of origin of CC and appears to increase from peripheral to large extrahepatic bile ducts CC (4). Guedj et al revealed that hilar and peripheral CC demonstrate different morphological features and display specific protein profiles, suggesting that hilar and peripheral CC may be considered to be distinct tumors that follow specific molecular pathways of carcinogenesis (15) .
Differentiating between ICC and metastatic CRC of the liver may be difficult by means of conventional histological examination. The use of K7 and K20 immunostaining is relevant for the differential diagnosis of ICC and metastatic CRC, due to the specific K profile of metastatic CRC (K7 -/K20 + ), which differs from that of ICC (K7 + /K20 -) (2) (3) (4) (5) . In the present study, K20 expression was observed in 35% of the 46 ICC patients, which was similar to earlier studies of K20 expression in 10-50% of ICCs (2, 3, 5, 8) . However, this result differs from other studies, in which K20 expression was evident in up to 71% of ICC tissues (4) . This discrepancy may be explained in part by the varied criteria for positivity, the different antibodies used and detection methods applied. In our study, K19 was expressed in 97.8% of ICC and 100% of primary and metastatic CRC cases. K19 is normally expressed in the lining of the gastroenteropancreatic and hepatobiliary tracts (16) . Therefore, K19 may not be useful in the differential diagnosis of ICC from metastatic CRC. Similar to previous studies (2-5), K7 was rarely positive, while in the present study K20 was usually positive in metastatic CRC. We identified that the combined K7/K20 immunophenotype was useful when making a differential diagnosis of ICC and metastatic CRC. The K7 + /K20 -profile was specific for ICC (100%), when compared with that of metastatic CRC, and the PPV of this phenotype for ICC diagnosis was 100%. In comparison, the K7 -/K20 + profile was specific for metastatic CRC (93.5%), when compared with that of ICC, and the PPV of this phenotype for metastatic CRC diagnosis was 84.2%. However, a precise analysis of clinicopathological features and the use of additional relevant markers are also required in cases of K7 + /K20 + tumors for correct diagnosis. ICC is the second most common type of primary malignant tumor, which demonstrates an extremely poor prognosis, despite combined therapeutic strategies (17, 18) . A recent large-scale study reported that factors associated with adverse prognosis in ICC included positive margin status, multiple lesions, T category, lymph node metastasis and vascular invasion (18). Similarly, we identified that T category, lymph node metastasis, tumor stage and vessel invasion were significantly associated with patient survival.
Developments in molecular techniques have improved our understanding of carcinogenesis in CC and confirmed the role of biomarkers, including mucins and Ks, in predicting a poor patient outcome (19) . Ks are intermediate filaments that form part of the cytoskeleton in epithelial cells; there is increasing interest in their application as prognostic biomarkers (19, 20) . Aishima et al identified that patients with ICC characterized by reduced K903 reactivity, which detects K1, K5, K10 and K14, displayed a significantly more favorable survival rate compared to those with preserved K903 reactivity (21) . A high serum K19 fragment is associated with tumor progression and poor outcome in patients with ICC (22) . The expression of K20 and its significance as a prognostic factor in ICC has not been elucidated. In the present study, the survival rate of patients with K20-positive ICC was lower than that of patients with K20-negative ICC; however, the difference was not significant. A longer term follow-up with a larger cohort is required to define the biological behavior of K20-positive ICC.
There is a strong correlation between the expression of mucin antigens and the survival of ICC patients (19) . MUC1 is important in the invasiveness and metastatic potential of CC, and usually correlates with a decreased survival (23) (24) (25) . In contrast to MUC1, MUC2 acts as a protective protein and is associated with a more favorable prognosis (26, 27) . MUC5AC is a gel-forming secreted mucin and serum MUC5AC is likely to be a poor prognostic factor in CC patients (28, 29) . In the present study, MUC6 expression was a good independent prognostic factor in ICC, which is consistent with previous findings (29, 30) . Further investigation is required to clarify the mechanisms of mucin expression associated with prognosis.
In conclusion, our study indicates that a proportion of ICC (35%) retains K20 expression, and combined immunostaining for K7 and K20 is useful when making a differential diagnosis of ICC and metastatic CRC. K20 expression is also significantly associated with gender, location and macroscopic growth pattern of tumor, intestinal phenotype and MUC2 expression. Finally, we identified that MUC6 expression in ICC is a good independent prognostic factor.
